An analysis involving around two million people has linked weight-loss drugs to improved heart health, fewer infections, a ...

The global drug delivery devices market size was valued at USD 280.98 billion in 2024 and is projected to reach from USD ...

People who take weight-loss drugs based on GLP-1 receptor agonists seem to have reduced risk for a litany of diseases, ...

This is called drug-induced cardiomyopathy when the heart enlarges and weakens over time. Medications may alter electrical ...

The study in Nature Medicine explores the potential wider benefits and risks of diabetes drugs GLP-1 receptor agonists.

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

A large new study has shed light on the wider health impacts of taking Ozempic-style drugs. Weight-loss drugs like Ozempic ...

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

Inflammation serves as a biological response to harmful stimuli, playing a crucial role in bodily defense but also leading to various chronic conditions ...

Drugs like Ozempic, Wegovy and Mounjaro were originally developed to manage type 2 diabetes, have now gained popularity for ...